Datoteka:Immune checkpoints of immunosuppressive actions associated with breast cancer.svg

Sadržaj stranice nije podržan na drugim jezicima.
S Wikipedije, slobodne enciklopedije

Izvorna datoteka(SVG datoteka, nominalno 512 × 402 piksela, veličina datoteke: 654 KB)

Sažetak

Opis
English: Immune checkpoints of inhibitory pathways are fundamental in the immune system to maintain self-tolerance and modulate immune responses. In breast cancer, some of these immune checkpoints and immunosuppressive factors have been associated with subtype specificity through their expressions on breast cancer cells. The different immune cells and their ligand-receptor interactions and secreted stimulatory growth factors, chemokines and cytokines are shown. The expression of these immune markers in the TME in breast cancer may or not be subtype-specific but are important in circumventing immune recognition or to immobilize effector T cells. Thus, the expression of these ligands and receptors may be associated with breast cancer stage and clinical outcome. (AKT. serine/threonine kinase or protein kinase B; ARG1. Arginase 1; Bcl-xL. B-cell lymphoma-xtra large; CAFs. Cancer-associated fibroblasts; CTLA4. cytotoxic T-lymphocyte-associated protein 4; ER− Estrogen Receptor Negative; GM-CSF. Granulocyte-Macrophage Colony-Stimulating Factor; HER2+. Human Epidermal Growth Factor Receptor 2; IDO. Indoleamine-2,3-dioxygenase; IFN-γ. interferon gamma; IFN-γR. interferon gamma receptor; IL. Interleukin; JAK. Janus kinase; iNOS. Inducible nitric oxide synthase; MDSC. Myeloid-derived suppressor cells; MHC. major histocompatibility complex; MMP. Matrix Metalloproteinases; mTOR. Mammalian target of rapamycin; MUC. Mucins; NK. natural killer; NF-κB. nuclear factor-κB; NLR. Neutrophil-lymphocyte ratio; NO. Nitric Oxide; PI3K. PI3K.phosphoinositide 3-kinase; PD-1. programmed death-1; PD-L1. Programmed death-ligand1; PGE2. Prostaglandin E2; PR−. Progesterone Receptor Negative; ROS. Reactive Oxygen Species; SHP. Src homology protein-tyrosine phosphatase; Siglec 9. Sialic acid-binding lectins 9; STAT. Signal transducer and activator of transcription; TAMs. Tumor-associated macrophages; TANs. Tumor-associated neutrophils; TGF-β. Transforming Growth Factor-beta; TIL. Tumor-Infiltrating Lymphocytes; TNBC. Triple Negative Breast Cancer; Treg. regulatory T cell; TCR. T cell receptor; VEGF. Vascular endothelial growth factor).[1]
Datum
Izvor https://doi.org/10.3390/cancers11081205
Autor Vanessa Barriga, Nyanbol Kuol, Kulmira Nurgali, and Vasso Apostolopoulos

Licenciranje

w:bs:Creative Commons
pripisivanje
This file is licensed under the Creative Commons Attribution 4.0 International license.
Slobodni ste:
  • da dijelite – da kopirate, distributirate i prenosite djelo
  • da remiksate – da prilagodite djelo
Pod sljedećim uslovima:
  • pripisivanje – Morate pripisati odgovarajuće autorske zasluge, osigurati link ka licenci i naznačiti jesu li napravljene izmjene. To možete uraditi na bilo koji razumni način, ali ne tako da se sugerira da davalac licence odobrava Vas ili Vašu upotrebu njegovog djela.
  1. Template:CC-notice

Captions

Add a one-line explanation of what this file represents
Immune checkpoints of immunosuppressive actions associated with breast cancer

Items portrayed in this file

prikazuje

media type engleski

image/svg+xml

Historija datoteke

Kliknite na datum/vrijeme da vidite verziju datoteke iz tog vremena.

Datum/vrijemeSmanjeni pregledDimenzijeKorisnikKomentar
trenutno22:20, 8 april 2020Smanjeni pregled verzije na dan 22:20, 8 april 2020512 × 402 (654 KB)Rob HurtUploaded a work by Vanessa Barriga, Nyanbol Kuol, Kulmira Nurgali, and Vasso Apostolopoulos from https://doi.org/10.3390/cancers11081205 Add to Library with UploadWizard

Sljedeća stranica koristi ovu datoteku:

Globalna upotreba datoteke

Sljedeći wikiji koriste ovu datoteku:

Metapodaci